HP
HealthInvest Partners Portfolio holdings
AUM
$234M
This Quarter Return
+3.77%
1 Year Return
+10.88%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$126M
AUM Growth
+$126M
(-17%)
Cap. Flow
-$30.7M
Cap. Flow
% of AUM
-24.44%
Top 10 Holdings %
Top 10 Hldgs %
74.71%
Holding
20
New
3
Increased
5
Reduced
7
Closed
5
Top Buys
| 1 |
United Therapeutics
UTHR
|
$7.69M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$7.52M |
| 3 |
Ironwood Pharmaceuticals
IRWD
|
$6.88M |
| 4 |
CVS Health
CVS
|
$6.4M |
| 5 |
Supernus Pharmaceuticals
SUPN
|
$1.81M |
Top Sells
| 1 |
Viatris
VTRS
|
$9.84M |
| 2 |
Collegium Pharmaceutical
COLL
|
$9.61M |
| 3 |
Teva Pharmaceuticals
TEVA
|
$8.83M |
| 4 |
ATRS
Antares Pharma, Inc.
ATRS
|
$6.86M |
| 5 |
Catalyst Pharmaceutical
CPRX
|
$5.85M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Ironwood Pharmaceuticals
IRWD
$214M
| $16.2M | 12.91% | 1,450,000 +615,000 | +74% | +$6.88M |
|
|
2
Supernus Pharmaceuticals
SUPN
$2.53B
| $14M | 11.13% | 534,000 +69,000 | +15% | +$1.81M |
|
3
Accuray
ARAY
$157M
| $9.78M | 7.79% | 1,975,000 +325,000 | +20% | +$1.61M |
|
4
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $9.64M | 7.68% | 660,000 +60,000 | +10% | +$877K |
|
|
BDSI
5
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $7.82M | 6.23% | 2,000,000 +425,000 | +27% | +$1.66M |
|
|
6
United Therapeutics
UTHR
$13.8B
| $7.69M | 6.13% | +46,000 | New | +$7.69M |
|
|
7
Vertex Pharmaceuticals
VRTX
$100B
| $7.52M | 5.99% | +35,000 | New | +$7.52M |
|
8
AbbVie
ABBV
$372B
| $7.47M | 5.95% | 69,000 -18,000 | -21% | -$1.95M |
|
9
Universal Health Services
UHS
$11.6B
| $7.2M | 5.74% | 54,000 -14,000 | -21% | -$1.87M |
|
10
Cencora
COR
$56.5B
| $6.49M | 5.17% | 55,000 -38,000 | -41% | -$4.49M |
|
11
McKesson
MCK
$85.4B
| $6.44M | 5.13% | 33,000 -20,000 | -38% | -$3.9M |
|
|
12
CVS Health
CVS
$92.8B
| $6.4M | 5.09% | +85,000 | New | +$6.4M |
|
13
Cardinal Health
CAH
$35.5B
| $6.32M | 5.03% | 104,000 -65,000 | -38% | -$3.95M |
|
14
Bristol-Myers Squibb
BMY
$96B
| $6.31M | 5.03% | 100,000 -46,000 | -32% | -$2.9M |
|
15
Cigna
CI
$80.3B
| $6.29M | 5.01% | 26,000 -21,000 | -45% | -$5.08M |
|
|
16
Collegium Pharmaceutical
COLL
$1.22B
| – | – | -480,000 | Closed | -$9.61M |
|
|
17
Catalyst Pharmaceutical
CPRX
$2.52B
| – | – | -1,750,000 | Closed | -$5.85M |
|
|
18
Teva Pharmaceuticals
TEVA
$21.1B
| – | – | -915,000 | Closed | -$8.83M |
|
|
19
Viatris
VTRS
$12.3B
| – | – | -525,000 | Closed | -$9.84M |
|
|
ATRS
20
DELISTED
Antares Pharma, Inc.
ATRS
| – | – | -1,720,000 | Closed | -$6.86M |
|